Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Oct 7, 2022 (4 years ago)

CEFUROXIME INTRAVITREAL SYR 1MG/0.1ML Solution in 1 mL syringe

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

CEFUROXIME INTRAVITREAL SYR 1MG/0.1ML Solution in 1 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

Drug: Cefuroxime

Recalling firm
Pharmacy Plus, Inc. dba Vital Care Compounder
Origin
MS, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0031-2023 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Cefuroxime recalls

See all
Class II · Moderate risk

Cefuroxime 10mg/mL INJ 0.5 mg

Presence of Particulate Matter: Particulate matter was reported in one lot of Cefuroxime by a physician after use of product.. FDA analysis identified the particulate as coring of the rubber stopper

Terminated Particulate / foreign matter Pacific Compounding Pharmacy & Consultations Inc D-1076-2019
Class III · Low risk

Cefuroxime

Subpotent Drug: The product is sub-potent prior to its 90-day beyond use date.

Terminated Wrong potency / content JCB Laboratories LLC D-0246-2018

Other recalls by Pharmacy Plus, Inc. dba Vital Care Compounder

All 2022 recalls
Class II · Moderate risk

Voriconazole Opth Solution 2% Sterile Soln

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Ongoing Sterility / contamination Pharmacy Plus, Inc. dba Vital Care Compounder D-0057-2023
Class II · Moderate risk

Vancomycin Intravitreal 1mg/0.1ml Solution

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Ongoing Sterility / contamination Pharmacy Plus, Inc. dba Vital Care Compounder D-0056-2023
Class II · Moderate risk

Talc

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Ongoing Sterility / contamination Pharmacy Plus, Inc. dba Vital Care Compounder D-0055-2023